Patients with systemic sclerosis commonly exhibit increased arterial stiffness, which may be predictive of the overall severity of the disease. The aim of the present study was to check the stability of parameters of arterial stiffness after 1 year in this population. ERAMS is a French multicentric prospective study designed to identify a link between arterial distensibility and outcome in 100 patients with systemic sclerosis. Arterial distensibility was evaluated by 24-h ambulatory monitoring of QKD interval along with blood pressure (BP) and heart rate (HR) (four measurements/hour). The index QKD 100-60 , which is linked to aortic distensibility, was calculated automatically. QKD 100-60 is the value of
Inroduction
It is increasingly recognized that markers of the physical properties of large arteries have prognostic value. This has been reported for hypertension 1, 2 and renal failure, 3 and in general, increased arterial stiffness have been associated with various markers of risk for cardiovascular disease. Arterial stiffness assessed through monitoring of QKD interval appears to be increased in patients with systemic sclerosis, 4 a complex condition, which as yet lacks simple markers of severity. An increase in the rigidity of large diameter arteries has been found using other methods in patients with systemic sclerosis. 5 These results are consistent with the report of an increase in prevalence of arterial disease in the lower limbs of patients with systemic sclerosis. 6 Preliminary data have indicated the potential interest of increase in arterial rigidity as determined QKD (which depends on pulse wave velocity) for 100 mm Hg sBP and 60 bpm HR. The reproducibility of QKD 100-60 was assessed on the first patients to be followed up for a complete year. So far the 100 patients have been recruited from 14 participating centres and 48 were re-evaluated after 1 year. QKD 100-60 was highly reproducible: 201 ± 6 vs 202 ± 18 msec, standard deviation of difference = 13 msec. In conclusion: determination of QKD 100-60 to assess arterial stiffness gives stable results over 1 year in patients with systemic sclerosis. by ambulatory measurement of the QKD interval as a criterion of severity of systemic sclerosis. 4 The QKD 100-60 (calculated value of the QKD for a 100 mm Hg systolic blood pressure (BP) and 60 bpm heart rate (HR)) was chosen as the main criteria as it is a better marker of arterial stiffness and allows comparisons for different levels in BP. A multicentre trial has been set up in France to evaluate the interest of this criterion in the prognosis of systemic sclerosis: Evaluation de la Rigidité Artérielle comme Marqueur pronostique des Sclérodermies) (ERAMS). The objective was to follow-up a population of 100 patients with systemic sclerosis over a period of 3 years and relate indices of arterial rigidity with severity scores of the condition and incidence of complications. Prior to this evaluation, we wanted to verify the stability of the initial ambulatory measurements of QKD interval in this population 1 year after inception.
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Methods
ERAMS study
ERAMS is a French multicentre study (24 centres) that has received approval from the Ethics Commit-Journal of Human Hypertension tee of Bordeaux. All patients included in this study signed a written consent form and had to fulfil the criteria for systemic sclerosis as defined by the American Rheumatism Association. 7 Patients had to present either a proximal systemic sclerosis or two out of the following criteria: sclerodactily, digit pulp ulcers or necrosis or fibrosis in two pulmonary fields. Their performance status had to be good enough as indicated by a Karnofsky index above 40%. 8 Patients with left ventricular failure (evidenced echocardiographically with a left ventricular fractional shortening of less than 20%) and/or a left bundle branch block were excluded. The recruited patients will be followed up over a period of 3 years (one visit at inclusion and three annual follow-ups).
On inclusion, we collected demographic and clinical data, the history of the condition, current treatment, the cutaneous impairment (modified Rodnan's score, 9 number of pulp necroses and interincisor distance), along with pulmonary (chest Xray, respiratory function and alveolo-capillary transfer of CO), renal (creatinaemia and proteinuria), cardiac (electrocardiographic, echocardiographic and clinical parameters) and digestive (diarrhoea, oesophagitis) findings. Immunological investigations were also carried out including assay of antinuclear, anti-centromere, anti-topo-isomerase I-SCL70 antibodies. At each annual follow-up, the investigator records the current treatment and evaluates the course of the condition from the progression of lesions of skin and viscera (lung, kidney, heart and digestive tract) and a 24-h ambulatory recording of the QKD interval. At the end of the 3-year study period, patients will be classified as progressors (including patients whose death was attributable to the condition) or non-progressors. Univariate and multivariate analyses will be employed to identify the prognostic significance of the initial QKD interval and to identify potential confounding factors. A random effect model will be employed to evaluate the alterations in QKD interval in the progressors and non-progressors.
Ambulatory measurement of the QKD interval
Ambulatory measurement of the QKD interval is based on measurement of the velocity of the pulse wave. The QKD interval is the time between the onset of the QRS wave on the ECG and detection of the last Korotkoff sound during auscultatory measurement of BP. Q represents QRS, K for Korotkoff and D for diastole as the interval is determined on the last audible sound. 10 This time, whose normal value is around 200 msec, 11 is the sum of two separate components: the systolic pre-ejection time that depends on heart rate and inotropism, and the time taken for the pulse wave to travel from the aortic arches to the microphone placed on the brachial artery, thus corresponding to an arterial segment which includes ascending aorta. The QKD interval is correlated with the velocity of the pulse wave. [12] [13] [14] This interval can be determined automatically during the ambulatory measurement of BP. Variations of the QKD interval as a function of spontaneous variations of BP and HR can thus be evaluated throughout the day and night, enabling calculation of the slope of variation of the QKD interval with SBP. Although this slope bears a direct relation to the distensibility of the arterial system, it is highly sensitive to measurement artefacts and is poorly reproducible. We have defined another index, 10 QKD 100-60 that normalizes the parameter to a given level of SBP (100 mm Hg) and of HR (60 bpm), which thus eliminates the influence of pre-ejection time and provides a better indicator of arterial function. QKD 100-60 falls with increase in arterial stiffness. This index can be measured automatically over a given length of time and eliminates the influence of the instantaneous value of BP during measurement of the pulse wave velocity. An auscultatory, ECG gated, device (Diasys Integra, Novacor, France) is used to measure BP and QKD interval simultaneously. The arm band of the auscultatory device is placed on the left arm, and programmed to take four measurements per hour over 24 h during the routine activity of the patient. Only recordings with at least 30 valid measurements are included in the analysis. The software (Diasysoft, Novacor, France) automatically calculates the mean of the parameters over a period of 24 h (SBP, diastolic BP (DBP), HR, QKD) and the slope of the relationships between QKD and SBP and QKD 100-60 .
Statistical analysis
The data at inclusion and 1 year later were compared using Student's t-test for paired variables. The variables analysed were the mean SBP, DBP, QKD and HR over 24 h, QKD 100-60 and the slope of variation of QKD with SBP. Diagrams illustrating the difference between two measurements of the same parameter (value on inclusion vs value at 1 year) as a function of the means are presented according to the recommendations of Bland and Altmann.
Results
To date, 100 patients with systemic sclerosis have been recruited and we have ambulatory recordings of BP at 1 year for 48 of them. The main details of these patients are listed in Table 1 . The average number of 24-h measurements of BP, HR and QKD was 80 ± 17 at inclusion and 77 ± 16 at 1 year. Mean BP of these patients was low, reflecting in most cases an effective treatment with calcium inhibitors. The analysis of reproducibility showed that values of BP, HR and QKD had not altered 1 year after inclusion ( Table 2) . Figures 1 and 2 illustrate the differences between the values on inclusion and at 1 year as a function of the means of the two values for mean SBP over 24 h and QKD 100-60 . QKD 100-60 , the main criteria of this study, shows a standard deviation of differences of 13 msec between the two recordings. However, the mean value of QKD over 24 h was more reproducible, and in view of the absence of any significant change in BP and HR over the 1-year period, this parameter gives a good indication of the stability of the arterial system (Figure 3) . The protocol prescribed allocation of the population into two groups for the final analysis (those with QKD 100-60 Ͻ 200 msec and those у200 msec, this value being the average value in normal patients aged 50-59 years 11 ). Table 3 shows the distribution of the 48 patients according to this criterion at inclusion and at 1 year. Only three patients progressed from normal to abnormal and seven from abnormal to nor- Figure 1 Paired difference between the two measurements (value at inclusion minus value at 1 year) are plotted against the average value (value at inclusion + value at 1 year/2). Figure 2 Paired difference between the two measurements (value at inclusion minus value at 1 year) are plotted against the average value (value at inclusion + value at 1 year/2).
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Figure 3
Paired difference between the two measurements (value at inclusion minus value at 1 year) are plotted against the average value (value at inclusion + value at 1 year/2). mal. Any relationship between an alteration in QKD and progression of the condition should emerge from an analysis of these sub-groups.
Discussion
Systemic sclerosis gives rise to numerous complications which are often severe. They involve the digestive tract, lungs and kidneys. The course of the Journal of Human Hypertension condition shows marked inter-individual variation and a prognosis is not easy to define. The gravity of the disease is usually assessed from a complex score, which takes account of both clinical manifestations and data from laboratory investigations (biological markers). Alteration of the physical properties of the large arteries appears to be related to the severity of the condition and could represent a simple marker of both gravity and progressivity.
In an attempt to test this idea, 100 patients with systemic sclerosis were recruited in the ERAMS study and will be followed up over 3 years. It was deemed important to check the stability of the main parameter under consideration, QKD 100-60 , over the study period.
The reproducibility of the ambulatory determinations of QKD has so far only been tested in a population of 28 normal individuals examined twice with an interval of 1 week between examinations. 15 The data obtained in the population of patients with systemic sclerosis showed that the reproducibility at 1 year was close to that found in the short term (standard deviation of the difference in QKD 100-60 at interval of 1 year of 13 msec in patients with systemic sclerosis vs 12 msec at 1 week in normal subjects). In this population the raw QKD value was even more stable as BP and heart rate remained unchanged during the period of survey. However the QKD100-60 is a more reliable marker of arterial stiffness as its calculation allows to eliminate the influence of the preejection period and to compare for different levels of BP at the time of measurements.
The stability of the measurement at 1 year in patients with systemic sclerosis may be interpreted in various ways: this period of observation may be too short to detect any deterioration in large arteries, or the rigidification may occur early in the course of the condition and be predictive of severity. However, any relationship between arterial rigidity and prognosis will have to await the final results of the 3-year follow-up of the initial population of 100 patients.
In conclusion, we show an excellent stability over a 1-year period for the ambulatory measurement of the QKD interval. In the ERAMS study, it provides support for the selection of this method of exploration of the physical properties of the large arteries in systemic sclerosis.
